These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8646681

  • 1. Extensive apoptosis in ductal carcinoma in situ of the breast.
    Bodis S, Siziopikou KP, Schnitt SJ, Harris JR, Fisher DE.
    Cancer; 1996 May 01; 77(9):1831-5. PubMed ID: 8646681
    [Abstract] [Full Text] [Related]

  • 2. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blamey RW, Ellis IO.
    Mod Pathol; 1994 Feb 01; 7(2):257-62. PubMed ID: 7911998
    [Abstract] [Full Text] [Related]

  • 3. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED, Alowami S, Snell L, Murphy LC, Watson PH.
    Breast Cancer Res; 2004 Feb 01; 6(4):R308-15. PubMed ID: 15217497
    [Abstract] [Full Text] [Related]

  • 4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Feb 01; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 5. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and grade.
    Sowter HM, Ferguson M, Pym C, Watson P, Fox SB, Han C, Harris AL.
    J Pathol; 2003 Dec 01; 201(4):573-80. PubMed ID: 14648660
    [Abstract] [Full Text] [Related]

  • 6. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
    Shen KL, Harn HJ, Ho LI, Yu CP, Chiu SC, Lee WH.
    Cancer; 1998 Jun 15; 82(12):2373-81. PubMed ID: 9635530
    [Abstract] [Full Text] [Related]

  • 7. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
    Padmore RF, Fowble B, Hoffman J, Rosser C, Hanlon A, Patchefsky AS.
    Cancer; 2000 Mar 15; 88(6):1403-9. PubMed ID: 10717623
    [Abstract] [Full Text] [Related]

  • 8. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL.
    Lab Invest; 1994 Jul 15; 71(1):67-72. PubMed ID: 8041120
    [Abstract] [Full Text] [Related]

  • 9. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
    Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.
    Hum Pathol; 2001 May 15; 32(5):487-93. PubMed ID: 11381366
    [Abstract] [Full Text] [Related]

  • 10. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.
    Breast Cancer Res; 2008 May 15; 10(5):R87. PubMed ID: 18928525
    [Abstract] [Full Text] [Related]

  • 11. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM, Chan JY, Soong R, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC.
    Breast Cancer Res Treat; 2009 Jan 15; 113(1):113-21. PubMed ID: 18256927
    [Abstract] [Full Text] [Related]

  • 12. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I, Dikicioglu E, Erkus M, Culhaci N, Kacar F, Ozkara E, Uyar M.
    Saudi Med J; 2005 Dec 15; 26(12):1889-96. PubMed ID: 16380768
    [Abstract] [Full Text] [Related]

  • 13. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E.
    Cancer Res; 1996 Nov 15; 56(22):5260-5. PubMed ID: 8912866
    [Abstract] [Full Text] [Related]

  • 14. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W.
    J Pathol; 1999 Mar 15; 187(4):396-402. PubMed ID: 10398097
    [Abstract] [Full Text] [Related]

  • 15. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
    de Roos MA, de Bock GH, de Vries J, van der Vegt B, Wesseling J.
    J Surg Res; 2007 Jun 01; 140(1):109-14. PubMed ID: 17291532
    [Abstract] [Full Text] [Related]

  • 16. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ.
    J Pathol; 2001 Jul 01; 194(3):327-33. PubMed ID: 11439365
    [Abstract] [Full Text] [Related]

  • 17. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD, Silverstein MJ.
    Surg Oncol Clin N Am; 1997 Apr 01; 6(2):385-92. PubMed ID: 9115503
    [Abstract] [Full Text] [Related]

  • 18. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
    Maxhimer JB, Pesce CE, Stewart RA, Gattuso P, Prinz RA, Xu X.
    J Am Coll Surg; 2005 Mar 01; 200(3):328-35. PubMed ID: 15737842
    [Abstract] [Full Text] [Related]

  • 19. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
    Boyages J, Delaney G, Taylor R.
    Cancer; 1999 Feb 01; 85(3):616-28. PubMed ID: 10091735
    [Abstract] [Full Text] [Related]

  • 20. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C, Serio G, Lepore G, Lettini T, Dalena AM, Pennella A, D'Eredità G, Valente T, Ricco R.
    J Exp Clin Cancer Res; 2003 Jun 01; 22(2):279-88. PubMed ID: 12866579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.